Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 5374746, 9 pages
http://dx.doi.org/10.1155/2016/5374746
Research Article

Comparison of Clinical Trajectories before Initiation of Renal Replacement Therapy between Diabetic Nephropathy and Nephrosclerosis on the KDIGO Guidelines Heat Map

1Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan
2Division of General Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan

Received 29 May 2015; Revised 23 August 2015; Accepted 5 October 2015

Academic Editor: Monika A. Niewczas

Copyright © 2016 Masanori Abe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Levey, P. E. de Jong, J. Coresh et al., “The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report,” Kidney International, vol. 80, no. 1, pp. 17–28, 2011. View at Publisher · View at Google Scholar
  2. A. J. Collins, R. N. Foley, C. Herzog et al., “US renal data system 2012 annual data report,” American Journal of Kidney Diseases, vol. 61, no. 1, supplement 1, article A7, pp. e1–e476, 2013. View at Publisher · View at Google Scholar
  3. M. Abe and K. Kalantar-Zadeh, “Haemodialysis-induced hypoglycaemia and glycaemic disarrays,” Nature Reviews Nephrology, vol. 11, no. 5, pp. 302–313, 2015. View at Publisher · View at Google Scholar
  4. S. L. White, S. J. Chadban, S. Jan, J. R. Chapman, and A. Cass, “How can we achieve global equity in provision of renal replacement therapy?” Bulletin of the World Health Organization, vol. 86, no. 3, pp. 229–237, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Nakai, Y. Watanabe, I. Masakane et al., “Overview of regular dialysis treatment in Japan (as of 31 December 2011),” Therapeutic Apheresis and Dialysis, vol. 17, no. 6, pp. 567–611, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group, “KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease,” Kidney International Supplements, vol. 3, no. 5, pp. 1–150, 2013. View at Google Scholar
  7. S. Matsuo, E. Imai, M. Horio et al., “Revised equations for estimated GFR from serum creatinine in Japan,” American Journal of Kidney Diseases, vol. 53, no. 6, pp. 982–992, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Japanese Society of Hypertension, “Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2009),” Hypertension Research, vol. 32, no. 4, pp. 4–107, 2009. View at Google Scholar
  9. J. Coresh, T. C. Turin, K. Matsushita et al., “Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality,” The Journal of the American Medical Association, vol. 311, no. 24, pp. 2518–2531, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. J. G. Heaf and L. S. Mortensen, “Uraemia progression in chronic kidney disease stages 3–5 is not constant,” Nephron: Clinical Practice, vol. 118, no. 4, pp. c367–c374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Li, B. C. Astor, J. Lewis et al., “Longitudinal progression trajectory of GFR among patients with CKD,” American Journal of Kidney Diseases, vol. 59, no. 4, pp. 504–512, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. O'Hare, A. Batten, N. R. Burrows et al., “Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis,” American Journal of Kidney Diseases, vol. 59, no. 4, pp. 513–522, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. R. J. Macisaac, E. I. Ekinci, and G. Jerums, “Markers of and risk factors for the development and progression of diabetic kidney disease,” American Journal of Kidney Diseases, vol. 63, no. 2, pp. S39–S62, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Skupien, J. H. Warram, A. M. Smiles et al., “The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease,” Kidney International, vol. 82, no. 5, pp. 589–597, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. A. S. Krolewski, “Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes,” Diabetes Care, vol. 38, no. 6, pp. 954–962, 2015. View at Google Scholar
  16. A. S. Krolewski, M. A. Niewczas, J. Skupien et al., “Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria,” Diabetes Care, vol. 37, no. 1, pp. 226–234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. B. A. Perkins, L. H. Ficociello, K. H. Silva, D. M. Finkelstein, J. H. Warram, and A. S. Krolewski, “Regression of microalbuminuria in type 1 diabetes,” The New England Journal of Medicine, vol. 348, no. 23, pp. 2285–2293, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Hovind, L. Tarnow, P. Rossing et al., “Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study,” British Medical Journal, vol. 328, no. 7448, pp. 1105–1108, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Gæde, L. Tarnow, P. Vedel, H.-H. Parving, and O. Pedersen, “Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria,” Nephrology Dialysis Transplantation, vol. 19, no. 11, pp. 2784–2788, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Araki, M. Haneda, T. Sugimoto et al., “Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes,” Diabetes, vol. 54, no. 10, pp. 2983–2987, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Steinke, A. R. Sinaiko, M. S. Kramer, S. Suissa, B. M. Chavers, and M. Mauer, “The early natural history of nephropathy in type 1 diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients,” Diabetes, vol. 54, no. 7, pp. 2164–2171, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Yamada, M. Komatsu, I. Komiya et al., “Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: the Kashiwa study,” Diabetes Care, vol. 28, no. 11, pp. 2733–2738, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. E. Molitch, A. I. Adler, A. Flyvbjerg et al., “Diabetic kidney disease: a clinical update from Kidney Disease: improving Global Outcomes,” Kidney International, vol. 87, no. 1, pp. 20–30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. H.-H. Parving, U. Smidt, A. Andersen, and P. Svendsen, “Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy,” The Lancet, vol. 321, no. 8335, pp. 1175–1179, 1983. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Shimizu, K. Furuichi, H. Yokoyama et al., “Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency,” Clinical and Experimental Nephrology, vol. 18, no. 2, pp. 305–312, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Taniwaki, Y. Nishizawa, T. Kawagishi et al., “Decrease in glomerular filtration rate in Japanese patients with type 2 diabetes is linked to atherosclerosis,” Diabetes Care, vol. 21, no. 11, pp. 1848–1855, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. R. J. MacIsaac, S. Panagiotopoulos, K. J. McNeil et al., “Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?” Diabetes Care, vol. 29, no. 7, pp. 1560–1566, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Yokoyama, H. Sone, M. Oishi, K. Kawai, Y. Fukumoto, and M. Kobayashi, “Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15),” Nephrology Dialysis Transplantation, vol. 24, no. 4, pp. 1212–1219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Penno, A. Solini, E. Bonora et al., “Clinical significance of nonalbuminuric renal impairment in type 2 diabetes,” Journal of Hypertension, vol. 29, no. 9, pp. 1802–1809, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Rigalleau, C. Lasseur, C. Raffaitin et al., “Normoalbuminuric renal-insufficient diabetic patients: a lower-risk group,” Diabetes Care, vol. 30, no. 8, pp. 2034–2039, 2007. View at Publisher · View at Google Scholar · View at Scopus